The immune system employs a coordinated arsenal of innate and adaptive mechanisms to combat viral infections. Understanding these antiviral responses is essential for developing vaccines, antiviral therapies, and strategies to counteract viral immune evasion.
Innate Antiviral Defense
The innate immune system provides the first line of defense against viruses, recognizing infection within minutes to hours through pattern recognition receptors (PRRs) that detect viral components. Toll-like receptors (TLRs) are key sensors: TLR3 detects double-stranded RNA (dsRNA) produced during viral replication, TLR7 and TLR8 recognize single-stranded RNA, and TLR9 detects unmethylated CpG DNA motifs common in viral genomes. RIG-I-like receptors (RLRs), including RIG-I and MDA5, are cytosolic sensors that detect dsRNA and trigger signaling through the adaptor MAVS. The engagement of these receptors activates transcription factors such as IRF3, IRF7, and NF-κB, leading to the production of type I interferons (IFN-α, IFN-β) and proinflammatory cytokines that establish an antiviral state.
Type I Interferon Response
Type I interferons are the central cytokines of the antiviral innate response. Upon secretion, IFN-α and IFN-β bind to the interferon-α/β receptor (IFNAR) on both infected and neighboring cells, activating the JAK-STAT signaling pathway. This leads to the transcription of hundreds of interferon-stimulated genes (ISGs) whose products directly inhibit viral replication. Key ISGs include protein kinase R (PKR), which phosphorylates eIF2α to inhibit protein synthesis; 2’,5’-oligoadenylate synthetase (OAS), which activates RNase L to degrade viral RNA; Mx proteins (MxA, MxB), which block viral nucleocapsid trafficking; and tetherin, which prevents the release of enveloped viruses by physically tethering budding virions to the cell surface.
Natural Killer Cells in Antiviral Immunity
Natural killer (NK) cells are innate lymphoid cells that kill virus-infected cells and produce cytokines such as IFN-γ and TNF-α. NK cell activity is regulated by the balance of activating receptors (NKG2D, natural cytotoxicity receptors) and inhibitory receptors that recognize MHC class I molecules. Many viruses downregulate MHC class I to evade cytotoxic T cells, but this loss of inhibitory signals activates NK cells through the missing-self recognition mechanism. NK cells also mediate antibody-dependent cell-mediated cytotoxicity (ADCC) through the Fc receptor CD16, linking innate and adaptive antiviral responses.
Adaptive Antiviral Immunity
Adaptive immunity develops over days but provides highly specific and long-lasting protection against viral pathogens. CD8+ cytotoxic T lymphocytes (CTLs) recognize viral peptides presented on MHC class I molecules and kill infected cells through the release of perforin and granzymes, activation of Fas-FasL death pathways, and secretion of antiviral cytokines such as IFN-γ. CD4+ helper T cells support the antiviral response by providing essential signals for B cell antibody production and CD8+ T cell activation, with Th1 cells being particularly important for antiviral immunity through IFN-γ production. Humoral immunity involves B cells that produce virus-specific antibodies, including neutralizing antibodies that block viral entry by binding to surface proteins, opsonizing antibodies that enhance phagocytosis, and antibodies that activate complement-mediated lysis of enveloped virions.
Viral Evasion of Immune Responses
Viruses have evolved diverse strategies to evade host immune responses. Antigenic variation through mutation of surface proteins allows influenza virus (antigenic drift) and HIV to escape pre-existing neutralizing antibodies. Some viruses, such as herpes simplex virus and human cytomegalovirus, encode proteins that interfere with MHC class I presentation, while others block interferon signaling — for example, the NS1 protein of influenza A virus inhibits RIG-I signaling and PKR activation. Latency, exemplified by herpesviruses and HIV, allows the viral genome to persist in a transcriptionally silent state that avoids immune recognition, with periodic reactivation ensuring transmission to new hosts. Adenoviruses and poxviruses produce decoy cytokine receptors that neutralize immune mediators such as TNF-α, IL-1, and chemokines.
Antiviral Effector Mechanisms
Complement activation contributes to antiviral defense through multiple mechanisms: the classical pathway is activated by antibody-virus complexes, the lectin pathway by mannose-binding lectin recognizing viral glycoproteins, and the alternative pathway by viral surfaces. Complement proteins can directly neutralize enveloped viruses by membrane attack complex (MAC) formation, opsonize viruses for phagocytosis, and enhance antibody responses. Autophagy also functions as an antiviral mechanism by degrading viral components in autolysosomes, delivering viral nucleic acids to endosomal TLRs for enhanced IFN production, and facilitating MHC class II presentation of viral antigens.
Immunopathology in Viral Infections
While immune responses are essential for controlling viral infections, they can also contribute to tissue damage. In severe influenza, an excessive inflammatory response (cytokine storm) characterized by high levels of TNF-α, IL-6, and IL-1β causes acute lung injury. In hepatitis B and C virus infections, liver damage is largely mediated by CTL killing of infected hepatocytes rather than direct viral cytopathic effects. Viral infections can also trigger autoimmune responses through molecular mimicry, as seen in Guillain-Barré syndrome following Campylobacter jejuni infection and potentially in post-viral syndromes.
